{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:38:51Z","timestamp":1777937931330,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.transci.2022.103598","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T07:30:12Z","timestamp":1668238212000},"page":"103598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma exchange and COVID 19"],"prefix":"10.1016","volume":"61","author":[{"given":"Evdoxia","family":"Ginikopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.transci.2022.103598_bib3","unstructured":"WHO announces COVID-19 outbreak a pandemic [Internet]. [cited 2022 May 29]. Available from: \u3008https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic\u3009."},{"key":"10.1016\/j.transci.2022.103598_bib4","unstructured":"W.H.O. Coronavirus (COVID-19) Dashboard [Internet]. [cited 2022 May 29]. Available from: \u3008https:\/\/covid19.who.int\u3009."},{"key":"10.1016\/j.transci.2022.103598_bib5","series-title":"Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]","author":"Cascella","year":"2022"},{"issue":"11","key":"10.1016\/j.transci.2022.103598_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2021.2294","article-title":"SARS-CoV-2 Variants of Concern in the United States\u2014Challenges and Opportunities","volume":"325","author":"Walensky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2022.103598_bib7","unstructured":"Coronavirus disease (COVID-19): Variants of SARS-COV-2 [Internet]. [cited 2022 Jun 5]. Available from: \u3008https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(covid-19)-variants-of-sars-cov-2\u3009."},{"key":"10.1016\/j.transci.2022.103598_bib8","unstructured":"CDC. Omicron Variant: What You Need to Know [Internet]. Centers for Disease Control and Prevention; 2022 [cited 2022 Jun 5]. Available from: \u3008https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/omicron-variant.html\u3009."},{"issue":"5","key":"10.1016\/j.transci.2022.103598_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044684","article-title":"Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada","volume":"11","author":"Wingert","year":"2021","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.transci.2022.103598_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.transci.2022.103598_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","article-title":"Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020","volume":"69","author":"Stokes","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.transci.2022.103598_bib12","unstructured":"Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. [cited 2022 Apr 27]; Available from: \u3008https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.40071\u3009."},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc5064","article-title":"Bench-to-bedside review: thrombocytopenia-associated multiple organ failure \u2013 a newly appreciated syndrome in the critically ill","volume":"10","author":"Nguyen","year":"2006","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.transci.2022.103598_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: faraway, so close!","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.transci.2022.103598_bib15","first-page":"e309","article-title":"An overview of hemophagocytic lymphohistiocytosis","volume":"46","author":"Esteban","year":"2017","journal-title":"Pedia Ann"},{"key":"10.1016\/j.transci.2022.103598_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: the evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.transci.2022.103598_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12959-019-0198-4","article-title":"Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease","volume":"17","author":"Chang","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.transci.2022.103598_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin Chim ActaInt J Clin Chem"},{"key":"10.1016\/j.transci.2022.103598_bib19","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.transci.2022.103598_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/20587392211000890","article-title":"The risk factors for severe patients with COVID-19 in China: a systematic review and meta-analysis","volume":"19","author":"Yue-liang","year":"2021","journal-title":"Eur J Inflamm"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41401-021-00627-2","article-title":"Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.transci.2022.103598_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijid.2020.10.003","article-title":"A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer","volume":"101","author":"Nagant","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal changes in cytokine\/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome","volume":"11","author":"Chien","year":"2006","journal-title":"Respirol Carlton Vic"},{"key":"10.1016\/j.transci.2022.103598_bib24","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transci.2022.103598_bib27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasma exchange in severe sepsis and septic shock: a prospective, randomised, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jca.21257","article-title":"Therapeutic plasma exchange: a technical and operational review: therapeutic Plasma exchange","volume":"28","author":"Kaplan","year":"2013","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib30","first-page":"71","article-title":"Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry","volume":"56","author":"Stegmayr","year":"2017","journal-title":"Transfus Apher Sci J World Apher Assoc J Eur Soc Haemapheresis"},{"key":"10.1016\/j.transci.2022.103598_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winters","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s13054-014-0699-2","article-title":"The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis","volume":"18","author":"Rimmer","year":"2014","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","article-title":"Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock","volume":"24","author":"Stahl","year":"2020","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib35","first-page":"e87","article-title":"Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock","volume":"12","author":"Patel","year":"2011","journal-title":"Pedia Crit Care Med J Soc Crit Care Med World Fed Pedia Intensive Crit Care Soc"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib36","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1016\/j.jinf.2004.08.017","article-title":"Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy","volume":"51","author":"Kawashima","year":"2005","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib37","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.transci.2016.09.015","article-title":"Therapeutic plasma exchange in primary hemophagocytic lymphohistiocytosis: Reports of two cases and a review of the literature","volume":"55","author":"Bosnak","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0961203320901594","article-title":"Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: \u2018of plasma exchange and immunosuppressive escalation strategies\u2019 - a single centre reflection","volume":"29","author":"Lorenz","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2022.103598_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-020-2836-4","article-title":"A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19","volume":"24","author":"Keith","year":"2020","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib41","first-page":"149","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-evidence-based Approach from the Writing Committee of the American Society for Apheresis: the Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"10239","key":"10.1016\/j.transci.2022.103598_bib42","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(20)31209-5","article-title":"COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?","volume":"395","author":"Maier","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"10.1016\/j.transci.2022.103598_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/aor.13748","article-title":"Additive treatment considerations in COVID-19\u2014The clinician\u2019s perspective on extracorporeal adjunctive purification techniques","volume":"44","author":"Swol","year":"2020","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.transci.2022.103598_bib44","article-title":"Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies","volume":"59","author":"Li","year":"2020","journal-title":"Transfus Apher Sci J World Apher Assoc J Eur Soc Haemapheresis"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib45","first-page":"248","article-title":"Application of plasma exchange for Covid-19 patients","volume":"25","author":"Turgutkaya","year":"2021","journal-title":"Ther Apher Dial Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther"},{"key":"10.1016\/j.transci.2022.103598_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13054-020-03070-7","article-title":"First do no harm\u2014beware the risk of therapeutic plasma exchange in severe COVID-19","volume":"24","author":"Stahl","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103598_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","article-title":"Therapeutic plasma exchange in adults with severe COVID-19 infection","volume":"99","author":"Khamis","year":"2020","journal-title":"Int J Infect Dis IJID Publ Int Soc Infect Dis"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib48","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jfma.2020.04.023","article-title":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19","volume":"119","author":"Lin","year":"2020","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib49","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib50","article-title":"Treatment for emerging viruses: convalescent plasma and COVID-19","volume":"59","author":"Brown","year":"2020","journal-title":"Transfus Apher Sci J World Apher Assoc J Eur Soc Haemapheresis"},{"key":"10.1016\/j.transci.2022.103598_bib51","unstructured":"COVID-19: Neurologic complications and management of neurologic conditions - UpToDate [Internet]. [cited 2022 Jun 11]. Available from: \u3008https:\/\/www.uptodate.com\/contents\/covid-19-neurologic-complications-and-management-of-neurologic-conditions\u3009."},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.transci.2022.103598_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117053","article-title":"Description of 3 patients with myasthenia gravis and COVID-19","volume":"417","author":"Rein","year":"2020","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/trf.16218","article-title":"Therapeutic plasma exchange for COVID-19-associated hyperviscosity","volume":"61","author":"Truong","year":"2021","journal-title":"Transfus"},{"issue":"23","key":"10.1016\/j.transci.2022.103598_bib55","doi-asserted-by":"crossref","first-page":"12526","DOI":"10.1073\/pnas.2006691117","article-title":"Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19","volume":"117","author":"Kesici","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2022.103598_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13054-020-02943-1","article-title":"Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure","volume":"24","author":"Honore","year":"2020","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/1744-9987.13568","article-title":"Potential limitations of plasma exchange in treatment of COVID-19 patients: How to overcome them?","volume":"25","author":"Daoud","year":"2021","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2022.103598_bib58","unstructured":"China finds promising coronavirus treatment in blood plasma from recovered patients [Internet]. Fortune. [cited 2022 May 22]. Available from: \u3008https:\/\/fortune.com\/2020\/02\/14\/china-coronavirus-treatment-blood-plasma-recovered-patients\/\u3009."},{"key":"10.1016\/j.transci.2022.103598_bib59","article-title":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19","volume":"214","author":"Ma","year":"2020","journal-title":"Clin Immunol Orlando Fla"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s13054-020-03241-6","article-title":"The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience","volume":"24","author":"Keith","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103598_bib61","article-title":"The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure","volume":"8","author":"Keith","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"10.1016\/j.transci.2022.103598_bib62","first-page":"455","article-title":"Therapeutic plasma exchange as a rescue therapy in patients with coronavirus disease 2019: a case series","volume":"130","author":"Adeli","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.transci.2022.103598_bib63","first-page":"618","article-title":"Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification. Int J Infect Dis IJID Off Publ Int Soc","volume":"96","author":"Wang","year":"2020","journal-title":"Infect Dis"},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16890","article-title":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients","volume":"190","author":"Zhang","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12872-020-01665-0","article-title":"Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report","volume":"20","author":"Faqihi","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13054-020-03171-3","article-title":"Plasma exchange in critically ill COVID-19 patients","volume":"24","author":"Morath","year":"2020","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105974","article-title":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19","volume":"56","author":"Shi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib68","first-page":"533","article-title":"Therapeutic plasma exchange therapy support for critical COVID-19: a case report","volume":"25","author":"Hua","year":"2021","journal-title":"Ther Apher Dial Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jca.21830","article-title":"Therapeutic plasma exchange in a critically ill Covid-19 patient","volume":"36","author":"Altmayer","year":"2021","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib70","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jmv.26630","article-title":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report","volume":"93","author":"Ragab","year":"2021","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.transci.2022.103598_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004613","article-title":"Plasma exchange: an effective rescue therapy in critically Ill patients with coronavirus disease 2019 infection","volume":"48","author":"Fernandez","year":"2020","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.transci.2022.103598_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102924","article-title":"The successful management of an elderly Covid-19 infected patient by plasma exchange","volume":"59","author":"Akkoyunlu","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2022.103598_bib73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbi.2020.05.022","article-title":"Plasma exchange treatment in COVID-19\u2013related autoimmune meningoencephalitis: case series","volume":"87","author":"Dogan","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib74","first-page":"227","article-title":"Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab","volume":"49","author":"Luo","year":"2020","journal-title":"Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci"},{"key":"10.1016\/j.transci.2022.103598_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.809823","article-title":"On therapeutic plasma exchange against severe COVID-19-associated pneumonia: an observational clinical study","author":"Cegolon","year":"2022","journal-title":"Front Nutr [Internet]"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib76","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244853","article-title":"Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study","volume":"16","author":"Kamran","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib78","article-title":"Therapeutic plasma exchange: a potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit","volume":"60","author":"Emeksiz","year":"2021","journal-title":"Transfus Apher Sci J World Apher Assoc J Eur Soc Haemapheresis"},{"issue":"10","key":"10.1016\/j.transci.2022.103598_bib79","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ajem.2020.07.019","article-title":"Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease","volume":"38","author":"Liu","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.transci.2022.103598_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transci.2022.103598_bib81","article-title":"Therapeutic plasma exchange: impact on survival in patients with Covid-19 [Internet]","author":"Fonseca-Gonz\u00e1lez","year":"2022","journal-title":"Review"},{"key":"10.1016\/j.transci.2022.103598_bib82","unstructured":"Search of: COVID-19 or coronavirus and plasmaferesis or therapeutic plasma exchange | plasmaferesis or therapeutic plasma exchange - Results on Map - ClinicalTrials.gov [Internet]. [cited 2022 May 26]. Available from: \u3008https:\/\/clinicaltrials.gov\/ct2\/results\/map?cond=COVID-19+OR+CORONAVIRUS+AND+PLASMAFERESIS+OR+THERAPEUTIC+PLASMA+EXCHANGE&intr=PLASMAFERESIS+OR+THERAPEUTIC+PLASMA+EXCHANGE&map=\u3009."},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib83","first-page":"235","article-title":"Does therapeutic plasma exchange have a role in resistant cytokine storm state of COVID-19 infection?","volume":"57","author":"Mamdouh Elsayed","year":"2021","journal-title":"Alex J Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244853","article-title":"Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study","volume":"16","author":"Kamran","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.transci.2022.103598_bib85","first-page":"201","article-title":"Efficacy of therapeutic plasma exchange alone or in combination with ruxolitinib for the treatment of Penn Class 3 and 4 cytokine release syndrome complicating COVID-19","volume":"3","author":"Gluck","year":"2021","journal-title":"J Cell Immunol"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib86","first-page":"106","article-title":"Expert recommendations on blood purification treatment protocol for patients with severe COVID-19","volume":"6","author":"Yang","year":"2020","journal-title":"Chronic Dis Transl Med"},{"issue":"2","key":"10.1016\/j.transci.2022.103598_bib87","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","article-title":"Citrate anticoagulation for continuous venovenous hemofiltration","volume":"37","author":"Oudemans-van Straaten","year":"2009","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.transci.2022.103598_bib88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jca.21222","article-title":"Anticoagulation techniques in apheresis: from heparin to citrate and beyond","volume":"27","author":"Lee","year":"2012","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib89","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/org.7.1.14027","article-title":"Plasma exchange therapy for thrombotic microangiopathies","volume":"7","author":"Nguyen","year":"2011","journal-title":"Organogenesis"},{"issue":"1","key":"10.1016\/j.transci.2022.103598_bib90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/AIT.2013.0002","article-title":"Complications in patients treated with plasma exchange in the intensive care unit","volume":"45","author":"Szczeklik","year":"2013","journal-title":"Anaesthesiol Intensive Ther"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222002981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222002981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:56Z","timestamp":1761468896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050222002981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1473050222002981"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103598","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma exchange and COVID 19","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103598"}}